Trending Posts

Lorem ipsum dolor sit amet, consectetur adipiscing elit
How AccurKardia’s Award-Winning AccurECG™ Platform Redefine ECG Diagnostics…

Key Highlights: A Landmark Recognition for a Game-Changing ECG Technology AccurKardia’s AccurECG™ has been named the “Best New…

ByByAnuja SinghJun 9, 2025
Can MIT and Recursion’s New AI Model Boltz-2…

Key Takeaways• Boltz-2 delivers AI-driven binding affinity predictions 1000x faster than traditional free energy methods—dramatically accelerating virtual screening…

ByByAnuja SinghJun 9, 2025
Is Optic and Mechanica’s AI Venture Model the…

Key Highlights Strategic Collaboration to Power AI-Led Biotech GrowthOptic, Inc., a pioneer in AI platforms for biopharma, has…

ByByAnuja SinghJun 8, 2025
Is the OBI Pharma–TegMine Therapeutics ADC Deal the…

Key Highlights 1. Powering the Next-Gen ADC Revolution: OBI’s GlycOBI® Meets TegMine’s TegMiner™The collaboration between Taiwan-based OBI Pharma…

ByByAnuja SinghJun 6, 2025
Can AI Reveal the Hidden Biology of Cancer?…

Key Highlights: AI Collaboration to Decode Cancer ComplexityIn a bold step to redefine cancer treatment, Aitia, a leader…

ByByAnuja SinghJun 6, 2025
Is Juvenescence’s Acquisition of Ro5 the Key to…

Key Insights Juvenescence Acquires Ro5 to Bolster AI Capabilities in Drug DiscoveryJuvenescence Limited, a clinical-stage AI-enabled biotech company,…

ByByAnuja SinghJun 6, 2025
Can AI Turn Biobank Data into Precision Drug…

Key Highlights Transforming Biobanks into AI-Driven EnginesElucidata, a U.S.-India based AI pioneer in life sciences, and Sapien Biosciences,…

ByByAnuja SinghJun 5, 2025
How Will Axxam and Molecular Health’s AI-Powered Alliance…

Key Highlights: Strategic Collaboration Targets Early Drug Discovery BottlenecksAnnounced on June 4, 2025, Molecular Health and Axxam have…

ByByAnuja SinghJun 5, 2025
Can Clairity’s FDA-Approved AI Breast Cancer Prediction Tool…

Key Highlights: AI-Driven Risk Prediction: A Breakthrough in Preventive OncologyBoston-based Clairity received FDA de novo authorization for Clairity…

ByByAnuja SinghJun 4, 2025

Latest Stories

Don’t miss our hot and upcoming stories
Can Syntis Bio’s $38M Series A Transform Oral Biologics for Obesity and Rare Diseases?

Key Highlights Funding to Advance Novel Oral TherapiesBoston-based Syntis Bio announced the close of its…

ByByAnuja SinghJul 4, 2025
Is Ochsner Health’s AI Strategy a Blueprint for Ethical, Effective Physician Support?

Key Highlights Physicians Demand Responsible AIAn AMA survey of nearly 1,200 physicians revealed strong consensus…

ByByAnuja SinghJul 3, 2025
FDA clears Felix NeuroAI, the first AI-powered noninvasive wristband for essential tremor relief for 7 Million Patients

Key Takeaways FDA Clears First AI-Driven Wristband for Essential TremorFasikl’s Felix NeuroAI Wristband has received…

ByByAnuja SinghJul 3, 2025
Can Argon AI’s $5.5M Funding Transform Biopharma with an AI-Native Workspace to End Data Drudgery?

Key Takeaways Argon AI Secures Strategic Backing for AI-Native Biopharma WorkspaceArgon AI has raised $5.5…

ByByAnuja SinghJul 3, 2025
Scroll to Top